Clinical Trials Logo
  1. Home
  2. Diabetic Foot Ulcer
  3. NCT04054804
  4. Details
NCT04054804 Clinical Trial

Digital Foot Check by Using the D-Foot, a New Software

Diabetic Foot Ulcer Clinical Trial

— D-Foot2019  

Official title:
Digital Foot Check by Using the D-Foot, a New Software

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04054804
Other study ID # D-Foot 2019
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 16, 2019
Est. completion date December 31, 2019

Study information
Verified date October 2020
Source Sahlgrenska University Hospital, Sweden
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Patients with diabetes should be thoroughly examined before they are provided with insoles and shoes. In the study the feet are examined with the help of a new software, the D-Foot. D-Foot includes questions and surveys. The aim of the of the study is evaluate how the patients experience the visit at the department of Prosthetics & Orthotics based on the digital foot check.

Description:

Patients with diabetes should be thoroughly examined before they are provided with insoles and shoes. The purpose of the foot examination is to determine whether the patient is at risk of developing diabetic foot ulcers (DFU). Risk factors are: neuropathy, peripheral angiopathy, foot deformities, skin pathologies, earlier history of DFU/amputation. With effective control and examination of the feet, foot complications, such as DFU, can be prevented. In the study the feet are examined with the help of a new software, the D-Foot. D-Foot includes questions and surveys. The aim of the of the study is evaluate how the patients experience the visit at the department of Prosthetics & Orthotics based on the digital foot check.

Recruitment information / eligibility
Status Completed
Enrollment 100
Est. completion date December 31, 2019
Est. primary completion date December 31, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria for patients: - To be diagnosed diabetes - Age = 18 years - To understand the Swedish language. Inclusion Criteria for certified prosthetist & orthotists - To work at the department - To be assigned to work with patients with diabetes at risk of developing foot ulcers. - Have completed the introduction course D-foot

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• D-Foot
A digital foot check i assessed by using the software D-Foot.

Locations
Country Name City State
Sweden Department of Prostetics & Orthotics Gothenburg Region Västragötaland

Sponsors (1)
Lead Sponsor Collaborator
Sahlgrenska University Hospital, Sweden

Country where clinical trial is conducted

Sweden, 

Outcome
Type Measure Description Time frame Safety issue
Primary The questionnaire Orthotic and Prosthetic Users Survey (OPUS) will be used. Participants satisfaction with devices and services at the Department of Prosthetics and Orthotics will be evaluated. 2019-2020
Secondary Presence of neuropathy (number) From the software, D-Foot, the number of participants having neuropathy will be reported. 2019-2020
Secondary Presence of neuropathy (percentage) From the software, D-Foot, the percentage of participants having neuropathy will be reported 2019-2020
Secondary Presence of peripheral angiopathy (number ) From the software, D-Foot, the number of participants having peripheral angiopathy will be reported. 2019-2020
Secondary Presence of peripheral angiopathy (percentage ) From the software, D-Foot, the percentage of participants having peripheral angiopathy will be reported. 2019-2020
Secondary Presence of calluses (number) From the software, D-Foot, the number of participants having calluses will be reported. 2019-2020
Secondary Presence of calluses (percentage) From the software, D-Foot, the percentage of participants having calluses will be reported, 2019-2020
Secondary Presence of foot deformities (number) From the software, D-Foot, the number of participants having foot deformities eg. hammertoes, hallux valgus will be reported. 2019-2020
Secondary Presence of foot deformities (percentage) From the software, D-Foot, the percentage of participants having foot deformities eg. hammertoes, hallux valgus will be reported. 2019-2020
Secondary Presence of foot ulcers (number) From the software, D-Foot, the number of participants having foot ulcers will be reported. 2019-2020
Secondary Presence of foot ulcers (percentage) From the software, D-Foot, the percentage of participants having foot ulcers will be reported. 2019-2020
Secondary Presence of previous foot ulcers (number) From the software, D-Foot, the number of participants with previous foot ulcers will be reported. 2019-2020
Secondary Presence of previous foot ulcers (percentage) From the software, D-Foot, the percentage of participants with previous foot ulcers will be reported. 2019-2020
Secondary Presence of previous amputation in the lower extremities (number) From the software, D-Foot, the number of participants with previous amputation in the lower extremities will be reported. 2019-2020
Secondary Presence of previous amputation in the lower extremities (percentage) From the software, D-Foot, the percentage of participants with previous amputation in the lower extremities will be reported. 2019-2020
Secondary System Usability Scale (SUS). The score range from 0-100 and a SUS score above a 68 would be considered above average and anything below 68 is below average. The SUS provides a reliable tool for measuring the usability. It consists of a 10 item questionnaire with five response options for respondents; from Strongly agree to Strongly disagree. SUS allows you to evaluate a wide variety of products and services, including hardware, software, mobile devices, websites and applications. In this setting the aim is to evaluate how certified prosthetists & orthotists experience the use the web program D-Foot when they examine the patients feet? 2019-2020
See also
  Status Clinical Trial Phase
Recruiting NCT04497805 - Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot Ulcers Phase 2
Withdrawn NCT03675269 - Adjunctive Hyperbaric Oxygen Therapy (HBOT) for Lower Extermity Diabetic Ulcer: N/A
Completed NCT04624516 - Effect of Self-foot Exercise on the Incidence of Plantar Foot Diabetic Ulcer Recurrence N/A
Not yet recruiting NCT06439667 - VIRTUALLY SUPERVISED TELE-EXERCISE PLATFORM FOR ACCELERATING PLANTAR WOUND HEALING
Recruiting NCT05608187 - Evaluating Safety and Biological Effect on Wound Healing of ILP100-Topical in Subjects With Diabetic Foot Ulcers Phase 2
Not yet recruiting NCT06437028 - Evaluating the Efficacy of Perinatal Membrane Allografts for the Treatment of Diabetic Foot Ulcers. N/A
Not yet recruiting NCT06278935 - Lifestyle Tailored Offloading for Diabetic Foot Ulcers N/A
Withdrawn NCT05024656 - AmnioExcel® Plus vs SOC in the Management of Diabetic Foot Ulcers N/A
Terminated NCT02202668 - Transcutaneous Raman Spectroscope (TRS) Analyses of Diabetic Foot Ulcers N/A
Terminated NCT01966380 - Proof of Concept (Design Validation) in Patient With Hard to Heal Wounds Such as Pressure Ulcer, Diabetic Foot Ulcer and Leg Ulcer, Leia Phase 2
Completed NCT01951768 - Efficacy and Safety of Garamycin® Sponge in Diabetic Patients With a Moderate or Severe Foot Ulcer Infection Phase 4
Completed NCT01657474 - Comparative Study of Two Application Regimens of Amniotic Membrane Wound Graft In the Management of Diabetic Foot Ulcers N/A
Active, not recruiting NCT00389636 - TheraGauze™ Alone and Regranex®Gel 0.01% Plus TheraGauze™ in the Treatment of Wagner Stage I Diabetic Foot Ulcers N/A
Completed NCT01181440 - Dermagraft(R) for the Treatment of Patients With Diabetic Foot Ulcers Phase 3
Enrolling by invitation NCT05888259 - Plantar Pressure Distribution in Diabetic Foot Ulcer N/A
Not yet recruiting NCT05877378 - Efficacy of PICO Single-use System in Chronic Ulcers N/A
Recruiting NCT06037369 - The Short Message-based Customized Standardized N/A
Completed NCT03312595 - Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU) N/A
Recruiting NCT04564443 - A Unique Micro Water Jet Technology Device Versus Standard Debridement in the Treatment of Diabetic Foot N/A
Not yet recruiting NCT06444906 - A Two-Part, Randomized Study of Dermacyte® Amniotic Wound Care Matrix N/A